Insider · CIK 0001298814
Marsha Fanucci
Files at GENB (Generate Biomedicines, Inc.). First filing -, latest -.
In brief
Marsha Fanucci files SEC Form 4 as director at GENB (Generate Biomedicines, Inc.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Marsha Fanucci has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Planned sales
Form 144 notices this insider filed before selling restricted or control stock, newest first.
| Filed | Company | Shares | Value | Sale date | Past 3 months |
|---|---|---|---|---|---|
| Mar 14, 2025 | SYRS Syros Pharmaceuticals, Inc. | 9,333 0.03% of outstanding | $924 | Mar 14, 2025 | none |
Transactions
Every row this insider has filed, 1 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Feb 26, 2026 | GENB Generate Biomedicines, Inc. | AGrant or award Stock Option (Right to Buy)derivative | +29,561 | $0.00 | $0 | 29,561 | Mar 2, 2026 |
Questions about Marsha Fanucci
Answered from the filings on this page, as of the latest one.
Is Marsha Fanucci buying or selling?
Marsha Fanucci has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Marsha Fanucci's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Marsha Fanucci has 0.
Where does Marsha Fanucci file Form 4?
Marsha Fanucci has filed Form 4 at GENB (Generate Biomedicines, Inc.). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.